Kaplan-Meier analysis and Cox analyses of PDHA1 demonstrated that upregulated expression of PDHA1 was associated with worse OS and RFS outcome of BC patients, illustrating that PDHA1 has the potential to serve as a prognosis biomarker of BC. This evidence concerns the gene PDHA1 and breast cancer.